News
-
-
-
-
-
-
PRESS RELEASE
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
Lobe Sciences Ltd. to participate in Clusterbusters 20th Annual U.S. Patient Conference to highlight psilocin treatment for cluster headaches and discuss funding success for further research and development -
PRESS RELEASE
Gladstone Capital Corporation Prices Upsized Public Offering of 5.875% Convertible Notes due 2030
Gladstone Capital Corporation announces pricing of $130.0 million convertible notes due 2030, with additional conversion and redemption details. Oppenheimer & Co. Inc. acts as book-running manager -
-
-